Curaleaf Launches Adult-Use Cannabis Sales in Hudson Valley, NY
Ticker: CURLF · Form: 6-K · Filed: 2024-01-26T00:00:00.000Z
Sentiment: bullish
Topics: market-expansion, cannabis, new-product-launch, regulatory-change
TL;DR
**Curaleaf just opened its first adult-use dispensary in New York, big for growth!**
AI Summary
Curaleaf Holdings, Inc. announced on January 26, 2024, the launch of adult-use cannabis sales at its Hudson Valley, New York dispensary, located at 8 North Plank Road, Newburgh. This 3,500-square-foot facility, which has served medical patients since 2017 and added 1,750 square feet for expansion, is Curaleaf's first New York location to offer adult-use products. This expansion into the recreational market in New York could significantly boost Curaleaf's revenue and market share, making the stock more attractive to investors looking for growth in the cannabis sector.
Why It Matters
This marks Curaleaf's entry into New York's recreational cannabis market, potentially unlocking a significant new revenue stream and expanding its customer base beyond medical patients.
Risk Assessment
Risk Level: low — The filing reports a positive business development with minimal inherent risks, as it's an expansion into an existing legal market.
Analyst Insight
Investors should view this as a positive development, indicating Curaleaf's strategic expansion into a key recreational market. This could lead to increased revenue and market share, potentially making the stock more attractive for long-term growth in the cannabis sector.
Key Numbers
- 3,500-square-foot — Original facility size (Size of the Curaleaf Hudson Valley dispensary before expansion)
- 1,750 square feet — Added facility space (Expansion to accommodate adult-use sales at Hudson Valley)
- 2017 — Year medical sales began (When Curaleaf Hudson Valley started serving medical patients)
Key Players & Entities
- Curaleaf Holdings, Inc. (company) — the registrant and cannabis product provider
- Hudson Valley, New York (location) — site of the first adult-use dispensary
- January 26, 2024 (date) — date of the press release and filing
- Peter Clateman (person) — Chief Legal Officer who signed the filing
- 8 North Plank Road, Newburgh, New York (location) — specific address of the Curaleaf Hudson Valley dispensary
- 3,500-square-foot (dollar_amount) — original size of the facility
- 1,750 square feet (dollar_amount) — added space to the facility
- 2017 (date) — year Curaleaf Hudson Valley began supporting medical patients
Forward-Looking Statements
- Curaleaf's revenue from its New York operations will significantly increase due to the launch of adult-use sales. (Curaleaf Holdings, Inc.) — high confidence, target: Q1 2024 earnings report
- Curaleaf will open additional adult-use dispensaries in New York throughout 2024. (Curaleaf Holdings, Inc.) — medium confidence, target: End of 2024
FAQ
What is the primary purpose of this 6-K filing by Curaleaf Holdings, Inc.?
The primary purpose of this 6-K filing is to report the commencement of adult-use cannabis sales at Curaleaf's Hudson Valley, New York dispensary, effective January 24, 2024, as detailed in the press release dated January 26, 2024.
Where is the Curaleaf Hudson Valley dispensary located, and what is its significance?
The Curaleaf Hudson Valley dispensary is located at 8 North Plank Road, Newburgh, New York. It is significant because it is the Company's first retail location in New York to commence adult-use sales, expanding beyond its medical patient services since 2017.
Who signed this 6-K report on behalf of Curaleaf Holdings, Inc. and what is their title?
The 6-K report was signed by Peter Clateman, who holds the title of Chief Legal Officer for Curaleaf Holdings, Inc., on January 26, 2024.
What is the size of the Curaleaf Hudson Valley facility, and has it been expanded?
The Curaleaf Hudson Valley facility is a 3,500-square-foot facility. It has been expanded by adding 1,750 square feet to accommodate the new adult-use sales, making it a total of 5,250 square feet.
When did Curaleaf Hudson Valley begin supporting medical patients in New York?
Curaleaf Hudson Valley has been supporting medical patients in New York since 2017, prior to its expansion into adult-use sales.
From the Filing
0001756770-24-000002.txt : 20240126 0001756770-24-000002.hdr.sgml : 20240126 20240126161514 ACCESSION NUMBER: 0001756770-24-000002 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240126 FILED AS OF DATE: 20240126 DATE AS OF CHANGE: 20240126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 24567919 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 a6-kcover1.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: January 26, 2024 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated January 26 , 20 24 EX-99.1 2 pressrelease012624.htm EX-99.1 Document Curaleaf Celebrates Launch of Adult Use Sales at Hudson Valley, NY Dispensary Curaleaf Hudson Valley is the Company’s First New York Retail Location To Commence Adult Use Sales NEW YORK, January 24, 2024 – Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today celebrated the commencement of adult use sales at its Hudson Valley, New York location both in-person and through delivery. Located at 8 North Plank Road, Newburgh, New York, Curaleaf Hudson Valley is the Company’s first retail location to welcome adult use patrons in the state. Supporting medical patients in New York since 2017, Curaleaf Hudson Valley is a 3,500-square-foot facility conveniently located near I-84 for customers on the go. Curaleaf Hudson Valley has added 1,750 square feet to its facility to accommodate adult use consumers, including building a brand new sales floor area, product vault, additional parking, and additional space at the point of sales system. Medical patients and adult use consumers can enhance their individual cannabis journeys by exploring Curaleaf’s diverse product selection, across vapes, edibles and flower. The menu includes Select Briq Essentials, Select X Bites, Select Nano Bites, Grassroots premium flower, JAMS Jellies, JAMS Fast-Acting Jellies and soon FIND flower and B NOBLE pre-rolls and flower. Customers also now have access to free delivery, for anyone within fifteen miles of the Newburgh location, with a minimum purchase of $150. Same day delivery is available for all qualifying purchases made before 2:00 pm ET. “We are thrilled to commence adult use sales at our Hudson Valley retail location,” said Matt Darin, CEO Curaleaf. “Having served medical patients in the region for more than five years, we are eager to expand our services